- Home
- MBOT vs DXR Comparison
MBOT vs DXR Comparison
Compare MBOT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- DXR
- Stock Information
- Founded
- MBOT 2010
- DXR 1970
- Country
- MBOT United States
- DXR United States
- Employees
- MBOT N/A
- DXR N/A
- Industry
- MBOT Medical/Dental Instruments
- DXR Medical/Dental Instruments
- Sector
- MBOT Health Care
- DXR Health Care
- Exchange
- MBOT Nasdaq
- DXR Nasdaq
- Market Cap
- MBOT 32.7M
- DXR 37.6M
- IPO Year
- MBOT N/A
- DXR N/A
- Fundamental
- Price
- MBOT $1.99
- DXR $8.09
- Analyst Decision
- MBOT Strong Buy
- DXR Strong Buy
- Analyst Count
- MBOT 1
- DXR 1
- Target Price
- MBOT $7.00
- DXR $24.75
- AVG Volume (30 Days)
- MBOT 7.1M
- DXR 7.0K
- Earning Date
- MBOT 11-13-2024
- DXR 01-01-0001
- Dividend Yield
- MBOT N/A
- DXR N/A
- EPS Growth
- MBOT N/A
- DXR N/A
- EPS
- MBOT N/A
- DXR 0.35
- Revenue
- MBOT N/A
- DXR $154,205.00
- Revenue This Year
- MBOT N/A
- DXR N/A
- Revenue Next Year
- MBOT N/A
- DXR N/A
- P/E Ratio
- MBOT N/A
- DXR $23.58
- Revenue Growth
- MBOT N/A
- DXR N/A
- 52 Week Low
- MBOT $0.82
- DXR $7.19
- 52 Week High
- MBOT $3.38
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- MBOT 59.53
- DXR 46.69
- Support Level
- MBOT $1.59
- DXR $8.01
- Resistance Level
- MBOT $1.91
- DXR $8.50
- Average True Range (ATR)
- MBOT 0.44
- DXR 0.29
- MACD
- MBOT -0.01
- DXR 0.07
- Stochastic Oscillator
- MBOT 39.57
- DXR 61.44
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.